BPC-157
Research-use contextResearch-use peptide · also: bpc157, body protection compound 157, pentadecapeptide bpc 157
A synthetic peptide fragment sold as a research-use product; not an FDA-approved medicine.
People commonly track it for
Most often logged in a soft-tissue and gut recovery context. That reflects why people track it — not a proven effect.
Evidence summary
Evidence is predominantly preclinical (animal). Completed human clinical trials establishing safety or effectiveness are lacking.
Regulation & source status
Not FDA-approved. On the FDA's Category-2 compounding page it appears under 'nominated but withdrawn' (a withdrawal, not approval), and it is among the peptides under FDA compounding review as of July 2026 — being under review is not approval.
Route considerations
Commonly discussed as an injectable in community settings. We don't provide route, preparation, or technique guidance — that's a clinician/pharmacist conversation.
Storage considerations
Often sold as a powder for reconstitution; unregulated products have no verified storage or stability data. Storage specifics belong to a pharmacist, not this profile.
Interaction & context review
Because human data is limited, interactions aren't well characterized. If you track it alongside other items or medications, review the full list with a clinician or pharmacist.
Sport / duty status
Prohibited in sport — USADA lists BPC-157 under the WADA S0 (non-approved substances) category.
Track this item
You can log this as a custom peptide / medication-context item — record your own source status, route, storage note, and a schedule, and include it in an export for your clinician. StackWise doesn't add a dose.
Track this itemPeptide safety & source review
Sources
- FDA — Certain Bulk Drug Substances (compounding safety review)
- FDA — PCAC meeting, July 23–24, 2026 (503A bulks review)
- PMC — BPC-157 literature/patent review (2025)
- USADA — BPC-157 is prohibited
- DoD OPSS — BPC-157 prohibited peptide / unapproved drug
Source reviewed: 2026-07-23.